Possibly two of these problems solve each other? If access to the US market becomes a no-go for new drugs because of the FDA, then drug companies need to find a way to be profitable without such access, which would create pressure to reduce the cost of drug development including clinical trials? Americans would be left behind, while development might continue but more streamlined?
I wonder how long our political/​regulatory idiocy would continue, if it became the case that companies just… stopped bothering to make treatments available here, while the rest of the world got healthier for less money?
Possibly two of these problems solve each other? If access to the US market becomes a no-go for new drugs because of the FDA, then drug companies need to find a way to be profitable without such access, which would create pressure to reduce the cost of drug development including clinical trials? Americans would be left behind, while development might continue but more streamlined?
I wonder how long our political/​regulatory idiocy would continue, if it became the case that companies just… stopped bothering to make treatments available here, while the rest of the world got healthier for less money?